Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D<sub>3</sub> Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders.

Kehr, Jan; Wang, Fu-Hua; Ichinose, Fumio; Yoshitake, Shimako; Farkas, Bence; Kiss, Béla; Adham, Nika

Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D₃ Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders.

Kehr, Jan; Wang, Fu-Hua; Ichinose, Fumio; Yoshitake, Shimako; Farkas, Bence; Kiss, Béla; Adham, Nika.

Afiliação

Kehr J; Pronexus Analytical AB, Bromma, Sweden.
Wang FH; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Ichinose F; Pronexus Analytical AB, Bromma, Sweden.
Yoshitake S; Pronexus Analytical AB, Bromma, Sweden.
Farkas B; Pronexus Analytical AB, Bromma, Sweden.
Kiss B; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Adham N; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.

Front Psychiatry ; 12: 801641, 2021.

Article em En | MEDLINE | ID: mdl-35095615